Austedo, also known by its generic name deutetrabenazine, is a prescription medication primarily utilized to manage specific involuntary movement disorders.
Austedo Uses: Understanding Its Role in Managing Movement Disorders
Austedo, also known by its generic name deutetrabenazine, is a prescription medication primarily utilized to manage specific involuntary movement disorders. Developed to help individuals cope with challenging neurological conditions, Austedo plays a significant role in improving the quality of life for those affected.
What is Austedo?
Austedo is a medication classified as a vesicular monoamine transporter 2 (VMAT2) inhibitor. This mechanism of action allows it to modulate the release of certain neurotransmitters in the brain, which in turn helps to control and reduce the severity of involuntary movements. It is important to note that Austedo is not a cure for the underlying conditions it treats but rather a therapy designed to alleviate symptoms.
Primary Approved Uses of Austedo
Austedo has received approval for two distinct medical conditions, addressing the debilitating involuntary movements associated with each.
Austedo for Tardive Dyskinesia (TD)
Tardive dyskinesia is a neurological disorder characterized by repetitive, involuntary movements, often affecting the face, mouth, tongue, and sometimes the trunk and limbs. These movements can manifest as grimacing, lip-smacking, tongue protrusion, rapid eye blinking, or other uncoordinated motions. TD is commonly associated with the long-term use of certain medications, particularly antipsychotics.
Austedo is prescribed to help reduce the severity of these abnormal involuntary movements in adults with tardive dyskinesia. By modulating dopamine levels, Austedo helps to bring greater control over these movements, which can significantly improve a patient's comfort and social interaction.
Austedo for Huntington's Disease Chorea (HD Chorea)
Huntington's disease is a progressive neurodegenerative disorder that impacts a person's physical and mental abilities. One of the hallmark symptoms of Huntington's disease is chorea, which refers to involuntary, irregular, unpredictable, flowing, and jerky movements that can affect various parts of the body. These movements can interfere with daily activities such as walking, eating, and speaking.
Austedo is approved for the treatment of chorea associated with Huntington's disease. For individuals living with HD chorea, Austedo can help diminish the intensity and frequency of these involuntary movements, thereby assisting in the management of this challenging aspect of the disease.
How Austedo Works
As a VMAT2 inhibitor, Austedo works by reversibly blocking VMAT2, a protein responsible for packaging neurotransmitters like dopamine into vesicles for release into the synapse. By reducing the amount of dopamine available at the nerve endings, Austedo helps to decrease the overactivity of dopamine pathways implicated in the uncontrolled movements seen in tardive dyskinesia and Huntington's chorea. This targeted action allows for a reduction in the involuntary motor symptoms without completely depleting dopamine, which could lead to other issues.
Important Considerations Before Using Austedo
Austedo is a prescription medication and its use requires careful evaluation and ongoing supervision by a qualified healthcare professional. Before starting Austedo, a doctor will assess the patient's medical history, current medications, and the specific nature of their movement disorder. It is crucial for patients to discuss all existing medical conditions and any other drugs they are taking with their physician.
This information is intended for educational purposes only and should not be considered as medical advice. Always consult with a healthcare professional for diagnosis and treatment of any medical condition, including discussions about whether Austedo is an appropriate treatment option for you.